Elong Power Holding Limited's subsidiary, Elong Power (Beijing) Co., Ltd., has secured a three-year cooperation agreement worth at least RMB2 billion (about $300 million) to supply complete energy storage systems to domestic grid-side independent energy storage developers. The deal marks a significant breakthrough in Elong Power's core energy storage business, with the first contract valued at no less than RMB300 million ($45 million) starting January 2027. This agreement strengthens Elong Power's position in China's growing energy storage market and supports its dual strategy of domestic equipment supply and global distribution expansion. The company aims to enhance supply chain management and steadily increase energy storage equipment sales revenue over the next three years.
Elong Power Holding Limited's recent energy storage deal is context for readers following the energy sector. For readers following the energy sector, here is Pluang's market snapshot as of Nov 05, 2026 12:31 WIB: Of 79 priced energy-sector US stocks tradable on Pluang, 8 rose and 69 fell today. Notable movers include MPC at USD 390.00 with a -8.74% change and 76% sell order activity, RIG at USD 5.41 with a -8.31% change and 100% buy order activity, and DK at USD 65.00 with a -8.26% change.
Wolters Kluwer repurchased 499 of its ordinary shares between October 29 and November 4, 2026, spending €0.04 million at an average price of €85.06 per share. This is part of a larger 2026 share buyback program aiming to repurchase shares worth up to...
Lorenz Snacks has introduced a fleet of four autonomous, electric vehicles from Einride at its production site in Neunburg vorm Wald, Germany. These vehicles will handle in-plant transport of goods and materials, replacing diesel trucks and significa...
Futu Holdings Limited will announce its financial results for the third quarter ending September 30, 2026, on November 19 before U.S. market open. The company will host a live earnings conference call at 7:30 AM ET (8:30 PM Beijing/Hong Kong time) th...
UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...
T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...
